Dose-Dense Chemotherapy Enables Elimination of RT for the Majority of Low-Risk Pediatric Hodgkin Lymphomas: PHC Study HOD08 Authors: Jamie E. Flerlage, MD, MS; Angela M. Feraco, MD, MMSc; Yiwang Zhou, PhD; Ying Zheng, MS; Jia Liang, PhD; John T. Lucas, Jr, MD, MS; Alison M. Friedmann, MD, MSc; Howard J. Weinstein, MD; Torunn I. Yock, MD; Barry Shulkin, MD, MBA; Sue C. Kaste, DO; Lianna J. Marks, MD; Matthew J. Ehrhardt, MD, MS; Stephanie B. Dixon, MD, MPH; Scott Howard, MD; Pedro de Alarcon, MD; Sandra Luna-Fineman, MD; Amy E. Geddis, MD, PhD; Eric C. Larsen, MD; Karen Marcus, MD; Amy L. Billett, MD; Sarah S. Donaldson, MD; Melissa M. Hudson, MD; Monika L. Metzger, MD, MS; Matthew J. Krasin, MD; Michael P. Link, MD

https://www.medscape.org/viewarticle/1003274?impID=8203361&uac=148436CN&sso=true&src=wnl_tpal_260320_mscpedu